Janssen

Janssen gets EC approval for two new indications of Imbruvica
Janssen gets EC approval for two new indications of Imbruvica
Pharmaceutical Business Review
JNJ
Janssen
Europe
Imbruvica
Waldenström’s macroglobulinemia
chronic lymphocytic leukemia
Flag link:
Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%
Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%
Pharmaceutical Business Review
Janssen
Alligator Biosciences
CD40
cancer immunotherapy
Flag link:
Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial
Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial
BioSpace
Janssen
JNJ
ponesimod
Sanofi
Aubagio
relapsing multiple sclerosis
Flag link:
FDA quickly approves J&J’s Darzalex in multiple myeloma
FDA quickly approves J&J’s Darzalex in multiple myeloma
Pharmaforum
JNJ
Janssen
FDA
Darzalex
Multiple Myeloma
Flag link:
Time to fix pharma’s outdated business model
Time to fix pharma’s outdated business model
Pharmaforum
pharma industry
payers
patients
Janssen
Flag link:
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
JNJ
Janssen
Tremfya
clinical trials
psoriatic arthritis
Flag link:
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
Flag link:
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
KHN
FDA
Janssen
Spravato
esketamine
major depressive disorder
Flag link:
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
BioSpace
Janssen
clinical trials
patients
Flag link:
Janssen inks nference AI research pact
Janssen inks nference AI research pact
Fierce Biotech
JNJ
Janssen
R&D
artificial intelligence
nference
Flag link:
J&J passes key milestone in HIV vaccine trial
J&J passes key milestone in HIV vaccine trial
Pharmaforum
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Flag link:
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Forbes
depression
ketamine
esketamine
Spravato
JNJ
Janssen
Flag link:
Most people pay less than $5 per month for the drug. But some pay $11,002
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
JNJ
Janssen
Stelara
drug pricing
Flag link:
J&J's Balversa gets accelerated approval for bladder cancer
J&J's Balversa gets accelerated approval for bladder cancer
BioCentury
JNJ
Janssen
Balversa
bladder cancer
FDA
Flag link:
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
ViiV Healthcare
Dolutegravir
rilpivirine
JNJ
Janssen
HIV
Flag link:
Janssen laying off 4 dozen employees as California plant heads toward closure
Janssen laying off 4 dozen employees as California plant heads toward closure
Fierce Pharma
JNJ
Janssen
California
layoffs
drug manufacturing
Flag link:
Janssen, Scripps discover small molecule for flu
Janssen, Scripps discover small molecule for flu
BioCentury
JNJ
Janssen
Scripps Research Institute
Flu
influenza
small molecule drugs
Flag link:
Monthly shots control HIV as well as daily pills in two big studies
Monthly shots control HIV as well as daily pills in two big studies
Stat
HIV
AIDS
JNJ
Janssen
ViiV Healthcare
cabotegravir
Edurant
Flag link:
FDA approves Janssen's fast-acting depression therapy esketamine
FDA approves Janssen's fast-acting depression therapy esketamine
BioCentury
FDA
Spravato
esketamine
Janssen
JNJ
major depression
Flag link:
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
RAPS.org
Novartis
Janssen
JNJ
psoriasis
false advertising
Tremfya
Flag link:

Pages